Article Outline

Live longer with Sermorelin

Order Now
NAD+ injection Side
Secondary

Sermorelin vs CJC 1295 Differences, Cost, & Benefits

Key Takeaways

  • Sermorelin is the option available through a licensed clinician and pharmacy. It was once FDA-approved as Geref®, but the sermorelin that pharmacies prepare today is compounded and not FDA-approved.
  • CJC-1295 has never been FDA-approved. The FDA lists serious adverse events linked to it, including a raised heart rate.
  • Sermorelin acts for a short time, so it is usually injected at bedtime. CJC-1295 lasts about six to eight days in the body.
  • Adults who want growth hormone support through a legal prescription should talk with a licensed clinician about sermorelin.

When you compare sermorelin vs. CJC 1295, sermorelin is the option you can get through a licensed clinician and pharmacy. Both peptides signal the pituitary gland to release more growth hormone. The difference is that sermorelin has a regulated path to patients, and CJC-1295 does not.

The FDA confirmed in 2013 that Geref®, the brand form of sermorelin, was not removed for safety or effectiveness reasons. CJC-1295, by contrast, appears on an FDA list of substances with safety concerns.

This guide compares how each peptide works, how long it lasts, its side effects, cost, and safety.

Sermorelin vs. CJC 1295: A Quick Overview

Sermorelin CJC 1295
Active Ingredient Sermorelin acetate, the first 29 amino acids of natural GHRH CJC-1295, a modified GHRH fragment with an added part that binds to a blood protein called albumin
Drug Class GHRH analog (growth hormone-releasing hormone copy) GHRH analog
FDA-approved Use Cases Previously approved as Geref® Diagnostic (1990) and Geref® (1997). No FDA-approved product is on the market today None
Mechanism Signals the pituitary to release growth hormone in short pulses Signals the pituitary for several days after one dose
Best for Adults with a prescription who want a regulated peptide option Research settings only
Administration Injection under the skin, usually at bedtime Injection under the skin, weekly or every two weeks in studies
Typical Cost Ivy Rx: from $179 (as of October 2026), made in the USA, with a Rate Lock Guarantee No legal U.S. prescription price

‍

What Is Sermorelin?

Sermorelin is a lab-made copy of the first 29 amino acids of GHRH, the hormone that tells your pituitary gland to release growth hormone. It is the shortest piece of GHRH that keeps the full effect. Because it works through your own pituitary, your body's normal controls on growth hormone stay in place.

At a glance: Sermorelin

  • FDA approved Geref® Diagnostic in 1990 and Geref® in 1997.
  • The maker stopped selling Geref® in 2008, and the FDA later confirmed this was not for safety or effectiveness reasons.
  • Today, licensed pharmacies prepare sermorelin with a prescription. These compounded formulations are not FDA-approved.
  • It is injected under the skin, usually at bedtime.

Sermorelin comes in more than one form. The Ivy Rx guide on sermorelin sublingual vs. injection explains how the forms differ.

What Is CJC 1295?

CJC-1295 is a modified version of the same GHRH fragment, with an added part called DAC that attaches to albumin in the blood. This attachment keeps the drug in the body for days instead of minutes. A company called ConjuChem developed it in the early 2000s.

At a glance: CJC 1295

  • CJC-1295 has never been FDA-approved for any use.
  • The FDA lists it with substances that raise safety concerns, including increased heart rate and a whole-body reaction that widens blood vessels.
  • The FDA has not added it to the list of ingredients that pharmacies may use to compound drugs.
  • A Phase II trial stopped in July 2006 after a participant died. The cause was under investigation at the time.

Sermorelin vs. CJC-1295 Half-Life

CJC-1295 has an estimated half-life of 5.8 to 8.1 days. Sermorelin acts for a much shorter time, and studies in children gave it once a day at bedtime. This difference determines how often each one is dosed and how long side effects can last. 

  • Natural GHRH breaks down in minutes. In a study of natural GHRH in people, its half-life in the blood was 6.8 minutes. Sermorelin is a piece of this hormone and is also cleared quickly.
  • One CJC-1295 dose raised growth hormone for six days or more. In healthy adults, growth hormone levels rose two- to 10-fold for at least six days.
  • CJC-1295 raised IGF-1 for over a week. IGF-1, a marker of growth hormone activity, rose 1.5- to three-fold for nine to 11 days after one dose.
  • Pulses still happen on CJC-1295. A follow-up study found the body kept releasing growth hormone in pulses while levels stayed higher overall.
💡

Did you know? A long half-life means you cannot stop a drug's effects quickly. If a side effect starts on CJC-1295, it may last for more than a week after the dose.

The Ivy Rx guides on sermorelin vs ipamorelin and tesamorelin vs sermorelin compare sermorelin with two other growth hormone peptides.

Side Effects Comparison

Sermorelin's side effects are mostly mild and happen at the injection site. CJC-1295 has fewer studies, and the FDA has flagged heart rate and blood vessel reactions.

Sermorelin

  • Flushing and injection-site pain: A review of sermorelin use in children found that brief facial flushing and pain at the injection site were the most common side effects. 
  • Other effects: Redness, swelling, headache, dizziness, and mild nausea are possible side effects. These are usually short-lived.
  • Blood sugar: A review of growth hormone boosters found some raised blood sugar by making the body less sensitive to insulin. Most of that data came from a different drug, ibutamoren, so people with diabetes should be monitored.

CJC 1295

  • Heart rate and blood vessel reactions: The FDA has identified serious adverse events linked to CJC-1295, including increased heart rate and a reaction that widens blood vessels through the body.
  • Early study results: In the 2006 study of healthy adults, no serious adverse reactions were reported, and doses of 30 or 60 mcg per kg were described as relatively well tolerated.
  • Limited data: The FDA notes that available clinical data on CJC-1295 are limited. Long-term safety has not been studied.

For more detail, see the full guide to sermorelin side effects.

Cost Comparison

Sermorelin starts from $179 at Ivy Rx as of October 2026, and the price depends on your prescribed use. Ivy Rx Sermorelin Injections are made in the USA, and our Rate Lock Guarantee keeps your price the same at every dose. CJC-1295 has no legal prescription price in the U.S., because licensed pharmacies do not have an approved way to prepare it. 

A licensed clinician can review your goals and explain how your prescribed use affects the price. The Ivy Rx guides to sermorelin cost and getting a sermorelin prescription online cover pricing in more depth. 

Try Ivy Rx Sermorelin Injections

Ivy Rx offers Sermorelin Injections with licensed clinician review and pharmacy dispensing. Sermorelin starts from $179 as of October 2026, with free, temperature-controlled shipping and no insurance needed. Your medication is made in the USA, and our Rate Lock Guarantee keeps your price the same at every dose. See if sermorelin is right for you.

Ivy Rx Sermorelin injection vial, a prescription-only medication

How Sermorelin and CJC 1295 Are Administered

Both peptides are injected under the skin, but sermorelin is given at night several times a week while CJC-1295 was given weekly or less often in studies. The chart shows labeled, program, and research doses.

Sermorelin CJC 1295 (research doses only)
Route Injection under the skin Injection under the skin
Timing At bedtime Any time in studies
How often Ivy Rx: five nights per week, or as directed Once, or two to three doses given weekly or every two weeks in studies
Dose Dose studied in children: 30 mcg per kg once a day at bedtime. Adult doses are set by your clinician 30 or 60 mcg per kg in the 2006 study
Approved dose None today None

‍

Sermorelin

Sermorelin is injected into the fatty tissue under the skin, usually on the belly or thigh, at bedtime. Bedtime dosing lines up with the body's natural growth hormone release during sleep.

  • Do keep vials in the refrigerator at 36°F to 46°F.
  • Do rotate injection sites to reduce redness and swelling.
  • Don't double up after a missed dose. Skip it and resume the next night.
  • Don't change your dose without clinician guidance.

See the full sermorelin dosage guide for how clinicians adjust doses over time.

CJC 1295

No approved or legally compounded dose of CJC-1295 exists. The doses in the chart come from a 2006 research study and are not a guide for personal use.

  • Do take part only through a registered clinical trial if you want to try CJC-1295.
  • Do tell every clinician if you have used it, because it stays active for more than a week.
  • Don't buy products labeled "for research use only" to inject yourself.
  • Don't combine it with other growth hormone products without medical oversight.

Safety Considerations Before Starting Sermorelin or CJC 1295

Sermorelin was studied and approved as Geref® before the maker stopped selling it, so there are more human data on sermorelin than on CJC-1295. Compounded sermorelin is not FDA-approved. CJC-1295 has limited human data and FDA-listed safety concerns. 

Safety area Sermorelin CJC 1295
FDA approval history Geref® approved in 1990 and 1997, then stopped for non-safety reasons. Today’s compounded sermorelin is not approved Never approved
FDA safety listing Not listed Listed with safety concerns
How long effects last Short About six to eight days
Legal pharmacy access Yes, with a prescription No clear legal pathway
Allowed in sport No (banned by WADA) No (banned by WADA)

‍

Sermorelin

1. Active Cancer

Growth hormone and IGF-1 help cells grow. Active cancer, especially of the pituitary or hypothalamus, is typically a reason not to use sermorelin.

Tell your clinician about any past or current cancer. They may ask for more tests before you start.

2. Diabetes and Blood Sugar

Some growth hormone boosters have raised blood sugar in studies. And so, uncontrolled diabetes is another reason to avoid sermorelin without close medical supervision.

Your clinician may check blood sugar or HbA1c during treatment. They may also check IGF-1 to see how you are responding.

3. Pregnancy and Breastfeeding

Safety in pregnancy and breastfeeding has not been established. Thus, it’s not advisable to use sermorelin if you are pregnant, planning pregnancy, or breastfeeding.

CJC 1295

1. FDA-Listed Safety Concerns

The FDA has identified serious adverse events linked to CJC-1295, including increased heart rate and a blood vessel reaction. The FDA also notes risks from impurities and the body reacting to the peptide as a foreign substance.

2. Unknown Product Quality

CJC-1295 is not FDA-approved, so products sold online have not been checked by the FDA. Many are sold as "research chemicals," which are not made to the standards required for injectable drugs.

A product could contain the wrong dose, a different peptide, or contaminants. Injecting a non-sterile product can also cause infection.

3. Long-Lasting Effects and Limited Data

One dose of CJC-1295 raised IGF-1 for nine to 11 days in healthy adults. If a side effect starts, it may last well after the injection.

A Phase II trial stopped in 2006 after a participant died, and the drug was not developed further. No long-term human safety studies exist.

Who Might Choose Sermorelin or CJC 1295?

  • Adults seeking growth hormone support with a prescription: Sermorelin is available through a licensed clinician and pharmacy. The guide on how to get sermorelin prescribed walks through the steps.
  • Adults who prefer a peptide that works through their own pituitary: Sermorelin signals the pituitary to release growth hormone. Recombinant growth hormone is a separate prescription drug with its own risks.
  • People who prefer fewer injections: Some choose sermorelin in another form. The guide on sermorelin pills vs injections explains the trade-offs.
  • Research volunteers: CJC-1295 should only be used in a registered clinical trial.

Who Shouldn't Use Sermorelin or CJC 1295?

  • People with active cancer: Growth hormone signals can support cell growth, so avoid both peptides.
  • People who are pregnant or breastfeeding: Safety has not been established for either peptide.
  • Competitive athletes: WADA bans both sermorelin and CJC-1295 at all times, in and out of competition.
  • People with uncontrolled diabetes: Growth hormone boosters can raise blood sugar.
  • Anyone outside a clinical trial: CJC-1295 has no approved dose and no legal pharmacy source.

Can Sermorelin and CJC 1295 Be Used Together?

No, a licensed clinician should not combine them. Both act on the same GHRH receptor, and no published study has tested them together. CJC-1295 also has no legal pharmacy pathway in the U.S.

Online sellers often pair CJC-1295 with ipamorelin, another peptide. The FDA lists ipamorelin with safety concerns as well, including serious adverse events when given by vein.

Any change to peptide therapy should be guided by a licensed clinician, who can set the dose and monitor lab results. Insurance rarely covers compounded peptides, and it does not cover unapproved ones. Ivy Rx Sermorelin Injections are made in the USA and do not require insurance.

Get a Peptide Plan from Ivy Rx

If you want growth hormone support through a legal prescription, sermorelin is the option to discuss with a clinician. CJC-1295 has no approved dose and no licensed U.S. source, so it is not a practical choice today. To learn what results to expect, see if sermorelin works.

Start your Ivy Rx sermorelin assessment

Answer a short online health questionnaire, and a licensed clinician will review whether sermorelin fits your goals. Sermorelin starts from $179 as of October 2026, with no insurance needed. Your medication is made in the USA, and our Rate Lock Guarantee keeps your price the same at every dose. Pharmacy-prepared sermorelin is not an FDA-approved product. Start your assessment.

Ivy Rx Sermorelin injection vial, a prescription-only medication

FAQs

Is sermorelin FDA-approved?

No, not today. The FDA approved Geref® in 1990 and 1997, and the maker stopped selling it in 2008. Pharmacy-prepared sermorelin is available with a prescription but is not FDA-approved.

Is CJC-1295 legal to buy?

No legal U.S. pharmacy source exists. CJC-1295 is not FDA-approved, and the FDA lists it with safety concerns. Products sold online are not checked by the FDA.

Which lasts longer, sermorelin or CJC-1295?

CJC-1295 lasts much longer. Its half-life is about six to eight days. Sermorelin is cleared quickly, so it is usually injected at bedtime several nights a week.

Is CJC-1295 with ipamorelin better than sermorelin?

No study shows that. The FDA lists both CJC-1295 and ipamorelin with safety concerns. Sermorelin is the option available through a licensed clinician and pharmacy.

Do athletes need to avoid sermorelin?

Yes. WADA bans sermorelin, CJC-1295, and other GHRH analogs at all times. Athletes subject to testing should not use either peptide.

Disclaimer: Research findings, regulatory details, prescribing-label information, safety guidance, product availability, pricing, and treatment expectations in this article were reviewed in September 2026 and may change. This article is for informational purposes only and does not replace medical advice. Always confirm current product details, eligibility, dosing instructions, pharmacy or supplement sourcing, and program terms with a licensed clinician before starting treatment.

No items found.
Expert Pics: What to read next
CTA Gradient

Live longer with

Sermorelin

Order Now
Sermorelin anti-aging injection
Primary

Ivy RX patients

Members of Ivy RX branded medications were paid for their testimonials.

No items found.
References
  1. https://www.federalregister.gov/documents/2013/03/04/2013-04827/determination-that-geref-sermorelin-acetate-injection-05-milligrams-basevial-and-10-milligrams
  2. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
  3. https://pubmed.ncbi.nlm.nih.gov/18031173/
  4. https://pubmed.ncbi.nlm.nih.gov/16352683/
  5. https://pubmed.ncbi.nlm.nih.gov/17018654/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC423714
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/
  8. https://www.aidsmap.com/news/jul-2006/lipodystrophy-study-halted-after-patient-death
  9. https://zoek.officielebekendmakingen.nl/trb-2026-25.html

‍

Related

Resources